Hereditary angioedema in children and adolescents.
暂无分享,去创建一个
[1] J. Bernstein,et al. Long‐term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study , 2021, Allergy.
[2] A. Nicolas,et al. Impact de l’angiœdème héréditaire sur les activités de la vie quotidienne, la sphère émotionnelle et la qualité de vie des patients , 2021, La Revue de Médecine Interne.
[3] H. Iocca,et al. Long‐term safety and effectiveness of berotralstat for hereditary angioedema: The open‐label APeX‐S study , 2021, Clinical and translational allergy.
[4] W. Lumry,et al. Triggers of Exacerbation in Chronic Urticaria and Recurrent Angioedema-Prevalence and Relevance. , 2021, The journal of allergy and clinical immunology. In practice.
[5] J. Bernstein,et al. Consensus on treatment goals in hereditary angioedema: a global Delphi initiative. , 2021, The Journal of allergy and clinical immunology.
[6] K. Aggarwal,et al. Physician and patient perspectives on the management of hereditary angioedema: a survey on treatment burden and needs. , 2021, Allergy and asthma proceedings.
[7] T. Craig,et al. Short-term prophylaxis for children and adolescents with hereditary angioedema. , 2021, Allergy and asthma proceedings.
[8] L. Arruda,et al. Hereditary angioedema: how to approach it at the emergency department? , 2021, Einstein.
[9] J. Bernstein,et al. Recognition, Evaluation, and Management of Pediatric Hereditary Angioedema. , 2021, Pediatric emergency care.
[10] F. Minafra,et al. The Challenges in the Follow-Up and Treatment of Brazilian Children with Hereditary Angioedema , 2021, International Archives of Allergy and Immunology.
[11] Britta S. Möhl,et al. Novel hereditary angioedema linked with a heparan sulfate 3-O-sulfotransferase 6 gene mutation. , 2021, The Journal of allergy and clinical immunology.
[12] J. Pesquero,et al. The Panorama of Primary Angioedema in the Brazilian Population. , 2020, The journal of allergy and clinical immunology. In practice.
[13] T. Craig. Triggers and short-term prophylaxis in patients with hereditary angioedema. , 2020, Allergy and asthma proceedings.
[14] William H. Yang,et al. Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: a randomized, double-blind, placebo-controlled phase 3 trial. , 2020, The Journal of allergy and clinical immunology.
[15] T. Machnig,et al. Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence , 2020, Orphanet Journal of Rare Diseases.
[16] J. Bernstein,et al. US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema. , 2020, The journal of allergy and clinical immunology. In practice.
[17] B. Giannetti,et al. Hereditary Angioedema Attack in Utero and Treatment of the Mother and Fetus , 2020, Mayo Clinic proceedings. Innovations, quality & outcomes.
[18] A. Franzese,et al. The experience of living with a chronic disease in pediatrics from the mothers’ narratives: The Clinical Interview on Parental Sense of Grip on the Disease , 2020, Health psychology open.
[19] M. Margaglione,et al. A myoferlin gain‐of‐function variant associates with a new type of hereditary angioedema , 2020, Allergy.
[20] R. Krüger,et al. Hereditary angioedema in children and adolescents – A consensus update on therapeutic strategies for German‐speaking countries , 2020, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[21] G. Porebski,et al. Life-threatening laryngeal attacks in hereditary angioedema patients. , 2020, Otolaryngologia polska = The Polish otolaryngology.
[22] M. Cicardi,et al. Short-term prophylaxis in patients with angioedema due to C1-inhibitor deficiency undergoing dental procedures: An observational study , 2020, PloS one.
[23] S. Cichon,et al. International consensus on the use of genetics in the management of hereditary angioedema. , 2020, The journal of allergy and clinical immunology. In practice.
[24] M. López-Trascasa,et al. SERPING1 mutation update: Mutation spectrum and C1 Inhibitor phenotypes , 2019, Human mutation.
[25] M. Freda,et al. Caregivers’ Sensemaking of Children’s Hereditary Angioedema: A Semiotic Narrative Analysis of the Sense of Grip on the Disease , 2019, Front. Psychol..
[26] M. Levin,et al. Fresh frozen plasma for on-demand hereditary angioedema treatment in South Africa and Iran , 2019, The World Allergy Organization journal.
[27] William H. Yang,et al. Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks. , 2019, The journal of allergy and clinical immunology. In practice.
[28] I. Braenne,et al. Hereditary angioedema cosegregating with a novel kininogen 1 gene mutation changing the N‐terminal cleavage site of bradykinin , 2019, Allergy.
[29] A. Grumach,et al. Assessment on hereditary angioedema burden of illness in Brazil: A patient perspective. , 2019, Allergy and asthma proceedings.
[30] Moshe Y. Vardi,et al. A randomized trial of human C1 inhibitor prophylaxis in children with hereditary angioedema , 2019, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[31] K. Bork,et al. Management of patients with hereditary angioedema in Germany: comparison with other countries in the Icatibant Outcome Survey , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.
[32] J. Bernstein,et al. Efficacy of recombinant human C1 esterase inhibitor across anatomic locations in acute hereditary angioedema attacks. , 2018, Allergy and asthma proceedings.
[33] J. Bernstein,et al. Hereditary angioedema from the patient's perspective: A follow-up patient survey. , 2018, Allergy and asthma proceedings.
[34] R. Lockey,et al. The international WAO/EAACI guideline for the management of hereditary angioedema—The 2017 revision and update , 2018, Allergy.
[35] I. Braenne,et al. Hereditary angioedema with a mutation in the plasminogen gene , 2018, Allergy.
[36] S. Cichon,et al. Hereditary Angioedema with Normal C1 Inhibitor and F12 Mutations in 42 Brazilian Families. , 2017, The journal of allergy and clinical immunology. In practice.
[37] M. Margaglione,et al. Mutation of the angiopoietin‐1 gene (ANGPT1) associates with a new type of hereditary angioedema , 2017, The Journal of allergy and clinical immunology.
[38] W. Aberer,et al. Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema. , 2017, The journal of allergy and clinical immunology. In practice.
[39] J. Bernstein,et al. Angioedema in the emergency department: a practical guide to differential diagnosis and management , 2017, International Journal of Emergency Medicine.
[40] T. Machnig,et al. Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema , 2017, Allergy & rhinology.
[41] W. Lumry,et al. Subcutaneous Icatibant for the Treatment of Hereditary Angioedema Attacks: Comparison of Home Self-Administration with Administration at a Medical Facility. , 2017, The journal of allergy and clinical immunology. In practice.
[42] M. Triggiani,et al. International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency , 2016, Allergy.
[43] J. Bernstein,et al. Management of Children With Hereditary Angioedema Due to C1 Inhibitor Deficiency , 2016, Pediatrics.
[44] A. Pagnier,et al. Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema , 2016, Clinical and experimental immunology.
[45] T. Machnig,et al. Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema due to C1-esterase Inhibitor Deficiency. , 2016, The Journal of emergency medicine.
[46] K. Bork,et al. Hereditary angioedema with normal C1‐INH with versus without specific F12 gene mutations , 2015, Allergy.
[47] K. Beusterien,et al. Burden of Illness in Hereditary Angioedema: A Conceptual Model. , 2015, Acta dermato-venereologica.
[48] M. Triggiani,et al. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group , 2014, Allergy.
[49] K. Bork,et al. Risk of laryngeal edema and facial swellings after tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1 inhibitor concentrate: a retrospective study. , 2011, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[50] H. Longhurst. Management of acute attacks of hereditary angioedema: potential role of icatibant , 2010, Vascular health and risk management.